Dean Capital Management Purchases 13,941 Shares of Maximus, Inc. $MMS

Dean Capital Management boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 57.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,183 shares of the health services provider’s stock after acquiring an additional 13,941 shares during the quarter. Maximus accounts for 1.4% of Dean Capital Management’s portfolio, making the stock its 11th biggest holding. Dean Capital Management owned 0.07% of Maximus worth $3,489,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Richardson Financial Services Inc. boosted its position in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Maximus during the 2nd quarter valued at about $35,000. Cullen Frost Bankers Inc. bought a new position in shares of Maximus in the 3rd quarter worth approximately $38,000. Parkside Financial Bank & Trust lifted its stake in shares of Maximus by 27.2% in the 3rd quarter. Parkside Financial Bank & Trust now owns 1,118 shares of the health services provider’s stock worth $102,000 after purchasing an additional 239 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after buying an additional 163 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. Finally, Weiss Ratings lowered Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Maximus Stock Down 0.0%

MMS stock opened at $72.40 on Monday. The business’s 50-day moving average price is $84.50 and its 200-day moving average price is $85.67. The stock has a market cap of $3.95 billion, a P/E ratio of 11.02 and a beta of 0.59. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a twelve month low of $64.68 and a twelve month high of $100.00.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the firm posted $1.61 EPS. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 13th. Maximus’s dividend payout ratio is currently 20.09%.

Insider Buying and Selling at Maximus

In other news, CEO Bruce Caswell acquired 3,175 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were purchased at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the transaction, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at approximately $25,732,619.85. This trade represents a 0.98% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO David Mutryn bought 1,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average cost of $75.62 per share, with a total value of $75,620.00. Following the acquisition, the chief financial officer directly owned 40,037 shares in the company, valued at $3,027,597.94. This trade represents a 2.56% increase in their position. The disclosure for this purchase is available in the SEC filing. 1.80% of the stock is owned by company insiders.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.